Calidi Biotherapeutics, Inc. · AMEX:CLDI
Lincoln Alternative Strategies LLC reported a 14.46% stake in Calidi Biotherapeutics, Inc. (Schedule 13G)
Event Aug 20, 2025 · Filed Aug 27, 2025
Lincoln Alternative Strategies LLC reported a 14.46% stake in Calidi Biotherapeutics, Inc., 730,000 shares, as a passive investor on Aug 20, 2025. Filed Aug 27, 2025 (Schedule 13G).
- Stake
- 14.46%
- Shares
- 730,000
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Lincoln Alternative Strategies LLC | 14.46% | 730,000 |
Source
Related
- Calidi Biotherapeutics, Inc.
- Lincoln Alternative Strategies LLC
- Calidi Biotherapeutics, Inc. shareholders
- Schedule 13G/A · Lincoln Alternative Strategies LLC · Feb 10, 2026
- Schedule 13G · Armistice Capital, LLC · May 15, 2026
- Schedule 13D · Gavrilov Ognian Anguelov · Mar 31, 2026
- Schedule 13D · Gavrilov Ognian Anguelov · Mar 9, 2026
- Schedule 13G · Gavrilov Ognian Anguelov · Feb 4, 2026
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2025